TABLE 3.
Clinical features of patients with type 2 diabetes who survived an MI in the two cross-sectional studies
| Whole sample | KK | Q121 | |
|---|---|---|---|
| Gargano | n = 169 | n = 112 | n = 57 |
| Male (%) | 70.4 | 72.3 | 66.7 |
| Age (years) | 64 (9) | 64 (9) | 64 (8) |
| Smokers (%) | 44.0 | 47.6 | 37.0 |
| BMI (kg/m2) | 30.7 (4.8) | 30.6 (4.6) | 30.9 (5.3) |
| Hypertension (%) | 86.9 | 89.3 | 82.1 |
| Duration of diabetes (years) | 14.2 (9.5) | 14.7 (9.9) | 13.3 (8.5) |
| HbA1c (%) | 8.6 (2.0) | 8.6 (1.8) | 8.5 (2.2) |
| Treatment of hyperglycemia | |||
| Diet alone (%) | 7.2 | 5.4 | 10.9 |
| Oral hypoglycemic agents (%) | 40.4 | 38.7 | 43.6 |
| Insulin ± oral hypoglycemic agents (%) | 52.4 | 55.9 | 45.5 |
| Boston | n = 170 | n = 122 | n = 48 |
| Male (%) | 72.4 | 73.3 | 70.8 |
| Age (years) | 64.6 (7.9) | 64.7 (7.8) | 64.3 (8.1) |
| Smokers (%) | 69.3 | 66.9 | 75.6 |
| BMI (kg/m2) | 31.8 (5.9) | 31.3 (5.6) | 33.1 (6.4) |
| Hypertension (%) | 78.2 | 77.0 | 81.3 |
| Duration of diabetes (years) | 12.5 (9.3) | 11.8 (9.4) | 14.1 (9.1) |
| HbA1c (%) | 7.4 (1.4) | 7.5 (1.5) | 7.3 (1.3) |
| Treatment of hyperglycemia | |||
| Diet alone (%) | 5.3 | 4.1 | 8.3 |
| Oral hypoglycemic agents (%) | 42.9 | 47.5 | 31.3 |
| Insulin ± oral hypoglycemic agents (%) | 51.8 | 48.4 | 60.4 |
Data are expressed as number, percentage, or mean (SD).